Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2013 1
2014 1
2016 2
2017 2
2018 1
2019 2
2020 5
2021 7
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Results by year

Filters applied: . Clear all
Page 1
Formulated Phospholipids as Non-Canonical TLR4 Agonists.
Liang H, Lykins WR, Seydoux E, Guderian JA, Phan T, Fox CB, Orr MT. Liang H, et al. Among authors: seydoux e. Pharmaceutics. 2022 Nov 22;14(12):2557. doi: 10.3390/pharmaceutics14122557. Pharmaceutics. 2022. PMID: 36559051 Free PMC article.
mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
Stamatatos L, Czartoski J, Wan YH, Homad LJ, Rubin V, Glantz H, Neradilek M, Seydoux E, Jennewein MF, MacCamy AJ, Feng J, Mize G, De Rosa SC, Finzi A, Lemos MP, Cohen KW, Moodie Z, McElrath MJ, McGuire AT. Stamatatos L, et al. Among authors: seydoux e. Science. 2021 Mar 25;372(6549):1413-8. doi: 10.1126/science.abg9175. Online ahead of print. Science. 2021. PMID: 33766944 Free PMC article.
Interaction of biomedical nanoparticles with the pulmonary immune system.
Blank F, Fytianos K, Seydoux E, Rodriguez-Lorenzo L, Petri-Fink A, von Garnier C, Rothen-Rutishauser B. Blank F, et al. Among authors: seydoux e. J Nanobiotechnology. 2017 Jan 9;15(1):6. doi: 10.1186/s12951-016-0242-5. J Nanobiotechnology. 2017. PMID: 28069025 Free PMC article. Review.
Current in vitro approaches to assess nanoparticle interactions with lung cells.
Fytianos K, Drasler B, Blank F, von Garnier C, Seydoux E, Rodriguez-Lorenzo L, Petri-Fink A, Rothen-Rutishauser B. Fytianos K, et al. Among authors: seydoux e. Nanomedicine (Lond). 2016 Sep;11(18):2457-69. doi: 10.2217/nnm-2016-0199. Epub 2016 Aug 16. Nanomedicine (Lond). 2016. PMID: 27529369 Free article. Review.
Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects.
Jennewein MF, MacCamy AJ, Akins NR, Feng J, Homad LJ, Hurlburt NK, Seydoux E, Wan YH, Stuart AB, Edara VV, Floyd K, Vanderheiden A, Mascola JR, Doria-Rose N, Wang L, Yang ES, Chu HY, Torres JL, Ozorowski G, Ward AB, Whaley RE, Cohen KW, Pancera M, McElrath MJ, Englund JA, Finzi A, Suthar MS, McGuire AT, Stamatatos L. Jennewein MF, et al. Among authors: seydoux e. Cell Rep. 2021 Jul 13;36(2):109353. doi: 10.1016/j.celrep.2021.109353. Epub 2021 Jun 22. Cell Rep. 2021. PMID: 34237283 Free PMC article.
Isolation and Characterization of Cross-Neutralizing Coronavirus Antibodies from COVID-19+ Subjects.
Jennewein MF, MacCamy AJ, Akins NR, Feng J, Homad LJ, Hurlburt NK, Seydoux E, Wan YH, Stuart AB, Edara VV, Floyd K, Vanderheiden A, Mascola JR, Doria-Rose N, Wang L, Yang ES, Chu HY, Torres JL, Ozorowski G, Ward AB, Whaley RE, Cohen KW, Pancera M, McElrath MJ, Englund JA, Finzi A, Suthar MS, McGuire AT, Stamatatos L. Jennewein MF, et al. Among authors: seydoux e. bioRxiv [Preprint]. 2021 Mar 24:2021.03.23.436684. doi: 10.1101/2021.03.23.436684. bioRxiv. 2021. PMID: 33791692 Free PMC article. Updated. Preprint.
A single mRNA immunization boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection.
Stamatatos L, Czartoski J, Wan YH, Homad LJ, Rubin V, Glantz H, Neradilek M, Seydoux E, Jennewein MF, MacCamy AJ, Feng J, Mize G, De Rosa SC, Finzi A, Lemos MP, Cohen KW, Moodie Z, McElrath MJ, McGuire AT. Stamatatos L, et al. Among authors: seydoux e. medRxiv [Preprint]. 2021 Mar 10:2021.02.05.21251182. doi: 10.1101/2021.02.05.21251182. medRxiv. 2021. PMID: 33758873 Free PMC article. Updated. Preprint.
Development and Testing of a Spray-Dried Tuberculosis Vaccine Candidate in a Mouse Model.
Gomez M, Ahmed M, Das S, McCollum J, Mellett L, Swanson R, Gupta A, Carrigy NB, Wang H, Barona D, Bachchhav S, Gerhardt A, Press C, Archer MC, Liang H, Seydoux E, Kramer RM, Kuehl PJ, Vehring R, Khader SA, Fox CB. Gomez M, et al. Among authors: seydoux e. Front Pharmacol. 2022 Jan 21;12:799034. doi: 10.3389/fphar.2021.799034. eCollection 2021. Front Pharmacol. 2022. PMID: 35126135 Free PMC article.
Characterization of neutralizing antibodies from a SARS-CoV-2 infected individual.
Seydoux E, Homad LJ, MacCamy AJ, Parks KR, Hurlburt NK, Jennewein MF, Akins NR, Stuart AB, Wan YH, Feng J, Nelson RE, Singh S, Cohen KW, McElrath MJ, Englund JA, Chu HY, Pancera M, McGuire AT, Stamatatos L. Seydoux E, et al. bioRxiv [Preprint]. 2020 May 12:2020.05.12.091298. doi: 10.1101/2020.05.12.091298. bioRxiv. 2020. PMID: 32511342 Free PMC article. Updated. Preprint.
22 results